Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Steroid withdrawal from tacrolimus-based therapy in renal transplant patients.
Citterio F, Rigotti P, Scatà MC, Romagnoli J, Baldan N, Marchini F, Castagneto M. Citterio F, et al. Among authors: rigotti p. Transplant Proc. 2002 Aug;34(5):1707-8. doi: 10.1016/s0041-1345(02)02991-3. Transplant Proc. 2002. PMID: 12176545 Clinical Trial. No abstract available.
A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine.
Montagnino G, Sandrini S, Casciani C, Schena FP, Carmellini M, Civati G, Rigotti P, Cossu M, Altieri P, Salvadori M, Federico S, Stefoni S, Cambi V, Albertazzi A, Buoncristiani U, Berloco P, Segoloni G, Boschiero L, Sparacino V, Donati D, Turello E, Dal Canton A, Ponticelli C. Montagnino G, et al. Among authors: rigotti p. Transplant Proc. 2005 Mar;37(2):788-90. doi: 10.1016/j.transproceed.2004.11.033. Transplant Proc. 2005. PMID: 15848532 Clinical Trial.
Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial.
Gotti E, Perico N, Gaspari F, Cattaneo D, Lesti MD, Ruggenenti P, Segoloni G, Salvadori M, Rigotti P, Valente U, Donati D, Sandrini S, Federico S, Sparacino V, Mourad G, Bosmans JL, Dimitrov BD, Iordache BE, Remuzzi G. Gotti E, et al. Among authors: rigotti p. Transplant Proc. 2005 Jun;37(5):2037-40. doi: 10.1016/j.transproceed.2005.03.096. Transplant Proc. 2005. PMID: 15964332 Clinical Trial.
Tacrolimus is highly effective in both dual and triple therapy regimens following renal transplantation. Spanish and Italian Tacrolimus Study Group.
Segoloni G, Bonomini V, Maresca MC, Arisi L, Gonzalez-Molina M, Tarantino A, del Castillo D, Ortuño J, Carmellini M, Capdevila L, Arias M, Garcia J, Rigotti P. Segoloni G, et al. Among authors: rigotti p. Transpl Int. 2000;13 Suppl 1:S336-40. doi: 10.1007/s001470050356. Transpl Int. 2000. PMID: 11112027 Clinical Trial.
Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial.
Wlodarczyk Z, Squifflet JP, Ostrowski M, Rigotti P, Stefoni S, Citterio F, Vanrenterghem Y, Krämer BK, Abramowicz D, Oppenheimer F, Pietruck F, Russ G, Karpf C, Undre N. Wlodarczyk Z, et al. Among authors: rigotti p. Am J Transplant. 2009 Nov;9(11):2505-13. doi: 10.1111/j.1600-6143.2009.02794.x. Epub 2009 Aug 14. Am J Transplant. 2009. PMID: 19681813 Free article. Clinical Trial.
205 results